Autres langues Sun Pharmaceutical Industries Ltd.

Actions

SUNPHARMA

INE044A01036

Produits pharmaceutiques

Marché Fermé - NSE India S.E. 13:05:10 17/09/2026			Varia. 5j.	Varia. 1 janv.
1 867,30 ^INR	+0,74%		+0,13%	+8,58%

09/09	Sun Pharma implante un centre de trésorerie mondial au sein de la GIFT City en Inde	MT
09/09	Sun Pharma : Moody's et S&P attribuent respectivement les notes Baa1 et BBB+	MT

Autres langues

09/09	Sun Pharma Sets Up Global Treasury Center in India's GIFT City
09/09	Sun Pharma Assigned Baa1, BBB+ Ratings by Moody's, S&P
01/09	Global pharma companies that have publicly announced Trump drug pricing agreements
31/08	Trump announces new round of drug-pricing deals
05/08	CRISIL Keeps AAA Rating on Sun Pharmaceutical's Bank Facilities
31/07	Sun Pharmaceutical's Consolidated Net Profit Grows in Fiscal Q1
31/07	Sun Pharmaceutical Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2026
31/07	Sun Pharma's quarterly profit jumps on strength in specialty medicines
30/07	Sun Pharma Gets Brazil Approval for Semaglutide Injection
29/07	Sun Pharmaceutical Industries Limited Receives Approval to Manufacture and Market Semaglutide in Brazil
22/07	Trump will Generika-Produktion mit massiven Zöllen in die USA zwingen
21/07	South Africa regulator reviews 12 generic semaglutide applications
15/07	India's Sun Pharma wins South Africa approval to launch generic Ozempic
15/07	Sun Pharma Wins South Africa Approval for Generic Semaglutide
15/07	Sun Pharmaceutical Industries Limited Receives Approval to Manufacture and Market Generic Semaglutide in South Africa
10/07	India's Dr Reddy's posts worst week in 3 years as semaglutide setback stokes growth fears
25/06	Jefferies quarterly profit misses estimates as asset management weighs
24/06	Jefferies quarterly profit more than doubles on dealmaking, equities strength
20/06	Sun Pharma to acquire Innovcare Lifesciences for $28.7 million
20/06	Sun Pharmaceutical Industries Limited entered into an agreement to acquire Innovcare Lifesciences Private Limited for INR 2.7 billion.
10/06	Organon wins US approval to widen use of arthritis biosimilar drug
09/06	Organon Acquisition May Receive $1 Billion Commitment From State Bank of India
26/05	Sun Pharmaceutical Industries Limited Presents Updated Results from Locally Advanced Cutaneous Squamous Cell Carcinoma Expansion Cohort from Pivotal CK-301-101 Trial of UNLOXCYT (Cosibelimab-Ipdl) at ASCO 2026 Annual Meeting
26/05	Sun Pharma to present long-term follow-up data on Unloxcyt
22/05	Sun Pharmaceutical Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026